Vulvar and Vaginal Atrophy Due to Menopause
📧 Sign up to get email alerts when something new happens for Vulvar and Vaginal Atrophy Due to Menopause.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2024-02-15FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for VAGIFEM (estradiol) from Novo Nordisk, resulting in updated labeling for the product.
-
FDA label_change · 2017-11-01FDA Approved: VAGIFEM — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Vagifem (estradiol) by Novo Nordisk, resulting in changes to the labeling of this vaginal estrog…
-
FDA label_change · 2012-02-14FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Premarin Vaginal (conjugated estrogens), resulting in a labeling update.